This report was produced in collaboration with colleagues at the Medicines Discovery Catapult, a UK SPINE partner.
It is a guide to established best practice in drug discovery with a focus on interrogating the aetiology of age-associated multimorbidity.
It complements the drug discovery roadmap, case studies drawn from recent clinical trials illustrate regulatory strategies for such interventions.
